cabazitaxel,177Lu-PSMA-617
emcure,sanofi,novartis
['cabazitaxel', 'crpc']
you don't want to miss, #therap: 177lu-psma-617 (lupsma) vs cabazitaxel in mcrpc progressing after docetaxel os after median follow-up of 3 years (anzup 1603). #asco22 presentation by sun, jun 5th: 9:00 9:12 am edt 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology